Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms

NCT02881671 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2600

Last updated 2021-09-09

No results posted yet for this study

Summary

Identification of genes involved in congenital atrioventricular block and progressive Cardiac Conduction Disease.

Conditions

  • Congenital Complete Heart Block
  • Cardiac Conduction Defect Progressive

Interventions

GENETIC

genetic blood analysis

patients will undergo a blood sample (15 ml) to analyse their genetic profile

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • vincent PROBST, MD-PHD · Nantes University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02881671 on ClinicalTrials.gov